"Reduction, Replacement and Refinement -the Three Rs -are the basic tenets of EU research and other policies concerning the use of animals in scientific testing and experimentation."
So began a press release 2 issued in connection with a conference on Research into Alternatives to Animal Experimentation, held in Brussels on 9-10 July 2002, and organised by DG Research and the Joint Research Centre of the European Commission.
The conference was opened by the EU Research Commissioner, Philippe Busquin, who said, "This is a challenge for the research community, but it also encompasses a major effort to better organise research and development investment at the EU level. The Commission is committed to fostering the Three Rs, including through its own research funding, but we can only get good results if there is a joint effort between scientists, national administrations, industry, NGOs and European policy-makers. I hope we can mobilise all stakeholders to work better together, in line with the objectives of the European Research Area."
Key roles are seen for DG Research project funding programme and for the European Centre for the Validation of Alternative Methods (ECVAM), part of the Institute for Health & Consumer Protection of the JRC. The principal reason for this renewed interest in alternatives is revealed later in the press release:
"Research into alternative methods to animal experimentation and testing is more than ever a necessity. The new EU system for registration, evaluation, authorisation and restriction of chemical substances foresees risk assessment for 30,000 chemical substances by 2012 at a cost of 2.1 billion Euro. According to independent estimates, this would imply the use of several million animals."
Many of the presentations given by a wide variety of stakeholders are available on the DG Research Web site, at http://europa.eu.int/comm/research/info/ conferences/rrr/rrr_en.html.
My own talk followed one by Mrs Dagmar Roth-Behrendt MEP, who spoke about the importance to the European Parliament of animal welfare, with particular reference to the cosmetics testing issue (where confusion and conflict over the proposed seventh amendment to the Cosmetics Directive [Directive 76/768/EEC] provide other reasons for increasing attempts to develop and validate alternative test methods).
In the concluding remarks to my own talk, I echoed the theme introduced by Commissioner Busquin -all concerned must work better and must cooperate more effectively, if the benefits offered by alternatives are to be gained.
I said that, while talking is easy, taking effective action is much more difficult, and that, while I was encouraged that this conference had been organised, I would remain sceptical about the level of genuine commitment to alternatives to animal experiments until a number of concrete results were in place throughout the EU, including:
-an end to the use of chimpanzees -the adoption of the zero option for the use of all non-human primates, with a target date for its achievement -a significant reduction in the use of cats and dogs, leading to the adoption of zero options for their use, with a challenging timetable for their achievement -more-effective harmonised controls on the production, breeding and use of transgenic animals -a scientifically justifiable policy on "endocrine disruptors" and their identification -a credible and scientific strategy on hazard prediction and risk assessment for new and existing chemicals, which makes maximum use of non-animal methods -long-term stability for ECVAM, and the provision of adequate staffing levels and financial resources -a guarantee that the same principles and standards will be applied to the validation of new non-animal and animal tests -an effective campaign to ensure that scientifically validated non-animal tests and testing strategies are accepted and used throughout the world without delay
